Skip to main content

Lisa Kuhns, PhD, MD

News
10/17/2023
“Clinical treatment and management need to be multifaceted and consider not just pharmaceutical intervention but a holistic approach to the patient’s experience both during and after CDI, acknowledging the potential psychological and social...
“Clinical treatment and management need to be multifaceted and consider not just pharmaceutical intervention but a holistic approach to the patient’s experience both during and after CDI, acknowledging the potential psychological and social...
“Clinical treatment and...
10/17/2023
First Report Managed Care
News
06/24/2021
A group of researchers from the Mayo Clinic in Rochester, MN, reported their experiences with pediatric cutaneous malignancies.
A group of researchers from the Mayo Clinic in Rochester, MN, reported their experiences with pediatric cutaneous malignancies.
A group of researchers from the...
06/24/2021
The Dermatologist
News
08/16/2021
Patients with HS undergo a variety of treatments, but pain is still poorly controlled and the disease is often misdiagnosed.
Patients with HS undergo a variety of treatments, but pain is still poorly controlled and the disease is often misdiagnosed.
Patients with HS undergo a...
08/16/2021
The Dermatologist
News
12/03/2021
Biologic therapy may reduce cardiovascular risk in patients with psoriatic arthritis by reducing the inflammatory burden, according to a recent study.
Biologic therapy may reduce cardiovascular risk in patients with psoriatic arthritis by reducing the inflammatory burden, according to a recent study.
Biologic therapy may reduce...
12/03/2021
The Dermatologist
News
11/30/2022
Researchers performed a cross-sectional study on the clinical features and treatment approaches of pediatric HS.
Researchers performed a cross-sectional study on the clinical features and treatment approaches of pediatric HS.
Researchers performed a...
11/30/2022
The Dermatologist
News
03/23/2023
Researchers aimed to determine the effects of biological therapies on serious cardiovascular events in ankylosing spondylitis and psoriatic arthritis.
Researchers aimed to determine the effects of biological therapies on serious cardiovascular events in ankylosing spondylitis and psoriatic arthritis.
Researchers aimed to determine...
03/23/2023
The Dermatologist
News
11/03/2023
MLPs are a part of a national movement that aims to promote health and well-being for communities that have been marginalized and discriminated against. These partnerships can also be a powerful tool in the fight against racism in health...
MLPs are a part of a national movement that aims to promote health and well-being for communities that have been marginalized and discriminated against. These partnerships can also be a powerful tool in the fight against racism in health...
MLPs are a part of a national...
11/03/2023
Integrated Healthcare Executive
News
02/26/2024
Adolescent girls frequently use weight-loss products, highlighting the need for interventions to reduce their usage, according to a study published in JAMA Network Open.
Adolescent girls frequently use weight-loss products, highlighting the need for interventions to reduce their usage, according to a study published in JAMA Network Open.
Adolescent girls frequently use...
02/26/2024
Pharmacy Learning Network
News
04/05/2024
Potential red flags for large-vessel vasculitis in isolated polymyalgia rheumatica (PMR) include inflammatory back pain, significant pelvic involvement, widespread lower extremity pain, marked inflammatory response indicated by specific lab...
Potential red flags for large-vessel vasculitis in isolated polymyalgia rheumatica (PMR) include inflammatory back pain, significant pelvic involvement, widespread lower extremity pain, marked inflammatory response indicated by specific lab...
Potential red flags for...
04/05/2024
First Report Managed Care
News
06/24/2021
In adult patients with alopecia areata and at least 50% scalp hair loss, the oral JAK inhibitor baricitinib is a safe and effective treatment option.
In adult patients with alopecia areata and at least 50% scalp hair loss, the oral JAK inhibitor baricitinib is a safe and effective treatment option.
In adult patients with alopecia...
06/24/2021
The Dermatologist